Systemic Psoriasis Therapies and Comorbid Disease in Patients with Psoriasis: A Review of Potential Risks and Benefits June 1, 2019 Dr. Goldenberg is a consultant and speaker for Abbvie, Celgene, Eli Lilly & Co., Novartis, and SUN and a consultant for Amgen and UCB. CONTINUE READING »
